Xeris Biopharma Holdings, Inc. (XERS) Revenue by Year
Xeris Biopharma Holdings, Inc. generated $291.8M in revenue in fiscal year 2025. This represents an increase of 43.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $335.4M in revenue. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Xeris Biopharma Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XERS Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
XERS Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Xeris Biopharma Holdings, Inc. financials
Frequently Asked Questions
What was Xeris Biopharma Holdings, Inc.'s revenue in fiscal year 2025?
Xeris Biopharma Holdings, Inc. generated $291.8M in revenue in fiscal year 2025.
How fast is Xeris Biopharma Holdings, Inc.'s revenue growing?
Xeris Biopharma Holdings, Inc. (XERS) revenue rose by 43.7% year over year, from $203.1M to $291.8M in fiscal year 2025.
What is Xeris Biopharma Holdings, Inc.'s revenue over the last twelve months?
Xeris Biopharma Holdings, Inc. (XERS) reported $335.4M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Xeris Biopharma Holdings, Inc.'s revenue changed over the years?
Across the 6 fiscal years this page covers, Xeris Biopharma Holdings, Inc. (XERS) revenue went from $20.4M in fiscal year 2020 to $291.8M in fiscal year 2025.
What was Xeris Biopharma Holdings, Inc.'s revenue in the most recent quarter?
Xeris Biopharma Holdings, Inc. (XERS) reported $92.1M in revenue in Q2 2026. This represents an increase of 28.7% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Xeris Biopharma Holdings, Inc. (XERS) reported on that line in every period on record.